Effect of Reminders on Adherence

September 26, 2016 updated by: University of Pennsylvania

Prediction and Pre-commitment Mailings for Medication Adherence

The investigators seek to increase medication adherence of subjects. The investigators will send mailings to customers of an insurance company, asking them to predict or commit to a certain level of behavior. The investigators will measure whether this increases medication adherence.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The investigators seek to increase medication adherence of subjects. The investigators will send mailings to customers of an insurance company, asking them to predict or commit to a certain level of behavior. The investigators will measure whether this increases medication adherence. The investigators will send mailings to subjects once per month, and elicit responses via mail, phone, and web surveys.

Study Type

Interventional

Enrollment (Actual)

47088

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Pennsylvania
      • Philadelphia, Pennsylvania, United States, 19104
        • University of Pennsylvania

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • customers of the investigators' insurance company partner

Exclusion Criteria:

  • none

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Factorial Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Usual care control
No intervention, just usual care from the insurance company
Experimental: Reminder control
Send a reminder to subjects every month
Behavioral: Reminder
Remind people to take their medicine
Experimental: Anonymous prediction
Ask subjects to anonymously predict their upcoming medication adherence
Behavioral: Reminder
Remind people to take their medicine
Behavioral: Prediction mailing
Ask people to predict their upcoming medication adherence
Behavioral: Anonymity
Keep patient predictions and commitment anonymous
Experimental: Anonymous commitment
Ask subjects to anonymously commit to their upcoming medication adherence
Behavioral: Reminder
Remind people to take their medicine
Behavioral: Anonymity
Keep patient predictions and commitment anonymous
Behavioral: Commitment mailing
Ask people to commit to their upcoming medication adherence
Experimental: Identified prediction
Ask subjects to predict their upcoming medication adherence and report it
Behavioral: Reminder
Remind people to take their medicine
Behavioral: Prediction mailing
Ask people to predict their upcoming medication adherence
Behavioral: Identification
Ask patients to report their predictions and commitments
Experimental: Identified commitment
Ask subjects to commit to their upcoming medication adherence and report it
Behavioral: Reminder
Remind people to take their medicine
Behavioral: Commitment mailing
Ask people to commit to their upcoming medication adherence
Behavioral: Identification
Ask patients to report their predictions and commitments

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Medication refills
Time Frame: 6 months
frequency of refilling medication
6 months

Secondary Outcome Measures

Outcome Measure
Time Frame
Hemoglobin A1C
Time Frame: 6 months
6 months
LDL cholesterol
Time Frame: 6 months
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of Pennsylvania

Investigators

  • Principal Investigator: Katherine Milkman, Ph.D, University of Pennsylvania

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2014

Primary Completion (Actual)

June 1, 2015

Study Completion (Actual)

June 1, 2015

Study Registration Dates

First Submitted

April 3, 2015

First Submitted That Met QC Criteria

April 7, 2015

First Posted (Estimate)

April 8, 2015

Study Record Updates

Last Update Posted (Estimate)

September 27, 2016

Last Update Submitted That Met QC Criteria

September 26, 2016

Last Verified

September 1, 2016

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • H14P001

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hypertension

Clinical Trials on Reminder

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Georgia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe